Skip to content
Screener

Phathom Pharmaceuticals, Inc. PHAT Q3 2025 earnings

Reported October 30, 2025 · Before market open

Revenue$49.5MMiss by $7.9M
EPS-$0.15Beat by $0.15
Revenue estimate$57.4M
EPS estimate-$0.30

Next report

Date not yet announced

Financials

Q3 2025

Income statement

See full
Revenue$49.5M+203%
Gross profit$43.3M+209%
Operating income-$15.3M+78.4%
Net income-$30.0M+65.0%
EPS (diluted)-$0.41+68.9%

Balance sheet

See full
Cash & equivalents$135.2M-59.6%
Total debt$209.8M+18.9%
Total equity-$422.5M-126%
Total assets$240.3M-37.9%

Cash flow

See full
Operating cash flow-$14.1M+77.8%
CapEx$27.0K-38.6%
Free cash flow-$14.1M+77.8%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$835.01M-21.1%
Enterprise value$909.66M+1.0%
P/S5.7×-34.6×

Profitability

See full
Gross margin87.2%+3.7pp
Operating margin-145%-67.4pp
Net margin-186.5%-86.0pp
FCF margin-153.1%-69.8pp

Returns & leverage

See full
Current ratio2.2×-3.5×

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$49.5M+203%

By product

See full
Voquezna Product$49.5M+202%

FAQ

When did Phathom Pharmaceuticals, Inc. report Q3 2025 earnings?
Phathom Pharmaceuticals, Inc. (PHAT) reported Q3 2025 earnings on October 30, 2025 before market open.
What were Phathom Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
Phathom Pharmaceuticals, Inc. reported revenue of $49.5M and eps of $-0.15 for Q3 2025.
Did Phathom Pharmaceuticals, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $57.4M by $7.9M. EPS beat the consensus estimate of $-0.30 by $0.15.
How did Phathom Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 202.7% from $16.4M a year earlier and eps grew 88.6% from $-1.32.
Where can I find Phathom Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-250611) and the 10-Q periodic report (0001193125-25-257390) directly on SEC EDGAR. The filing index links above go to sec.gov.